Vaccine Manufacturer Viability

Available since June 2020
Mr. Benoit Hayman (DCVMN staff), with consultation from Nicolas Luther (PATH)

In order to navigate through the complex vaccine global market, this course brings up some discussions on the costs mitigating strategies and  viability frameworks on the indicators of business success involved in vaccine manufacturing.